An evaluation of Minor Groove Binders as anti-fungal and anti-mycobacterial therapeutics-Reference-Cited by-同舟云学术

An evaluation of Minor Groove Binders as anti-fungal and anti-mycobacterial therapeutics

Published:2017-08 Issue: Volume:136 Page:561-572
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Scott Fraser J.^ORCID,Nichol Ryan J.O.,Khalaf Abedawn I.,Giordani Federica^ORCID,Gillingwater Kirsten,Ramu Soumya,Elliott Alysha,Zuegg Johannes,Duffy Paula,Rosslee Michael-Jon,Hlaka Lerato,Kumar Santosh,Ozturk Mumin,Brombacher Frank,Barrett Michael,Guler Reto,Suckling Colin J.

Funder

Rosetrees Trust

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference35 articles.

1. Resistance to Anti-Infective Drugs and the Threat to Public Health

2. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi

3. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda

4. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

5. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic analysis of MCF7 breast cancer cells treated with MGBs reveals a profound inhibition of estrogen receptor genes;Bioorganic Chemistry;2024-10

2. Amidine containing compounds: Antimicrobial activity and its potential in combating antimicrobial resistance;Heliyon;2024-08

3. Strathclyde minor groove binders (S-MGBs) with activity against Acanthamoeba castellanii;Journal of Antimicrobial Chemotherapy;2024-07-09

4. Structure-based drug design of DNA minor groove binders and evaluation of their antibacterial and anticancer properties;European Journal of Medicinal Chemistry;2024-05

5. Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3;ACS Infectious Diseases;2022-11-29